晚期胃食管癌 III 期随机试验中的替代终点:Crit. Rev. Oncol./Hematol. 201 (2024) 104416]的更正。

IF 5.5 2区 医学 Q1 HEMATOLOGY
Joel Veas Rodríguez , Ana Prieto , Ester Vilaprinyo , Marta Bonet , Marc Diez , Antonieta Salud , Robert Montal
{"title":"晚期胃食管癌 III 期随机试验中的替代终点:Crit. Rev. Oncol./Hematol. 201 (2024) 104416]的更正。","authors":"Joel Veas Rodríguez , Ana Prieto , Ester Vilaprinyo , Marta Bonet , Marc Diez , Antonieta Salud , Robert Montal","doi":"10.1016/j.critrevonc.2024.104466","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":11358,"journal":{"name":"Critical reviews in oncology/hematology","volume":"202 ","pages":"Article 104466"},"PeriodicalIF":5.5000,"publicationDate":"2024-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1040842824002099/pdfft?md5=8747da7c73c1b8b6325c92c3f9bf325c&pid=1-s2.0-S1040842824002099-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Corrigendum to “Surrogate endpoints in phase III randomized trials of advanced gastroesophageal cancer: A systematic review and meta-analysis” [Crit. Rev. Oncol./Hematol. 201 (2024) 104416]\",\"authors\":\"Joel Veas Rodríguez , Ana Prieto , Ester Vilaprinyo , Marta Bonet , Marc Diez , Antonieta Salud , Robert Montal\",\"doi\":\"10.1016/j.critrevonc.2024.104466\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":11358,\"journal\":{\"name\":\"Critical reviews in oncology/hematology\",\"volume\":\"202 \",\"pages\":\"Article 104466\"},\"PeriodicalIF\":5.5000,\"publicationDate\":\"2024-08-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S1040842824002099/pdfft?md5=8747da7c73c1b8b6325c92c3f9bf325c&pid=1-s2.0-S1040842824002099-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Critical reviews in oncology/hematology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1040842824002099\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Critical reviews in oncology/hematology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1040842824002099","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

本文章由计算机程序翻译,如有差异,请以英文原文为准。
Corrigendum to “Surrogate endpoints in phase III randomized trials of advanced gastroesophageal cancer: A systematic review and meta-analysis” [Crit. Rev. Oncol./Hematol. 201 (2024) 104416]
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
11.00
自引率
3.20%
发文量
213
审稿时长
55 days
期刊介绍: Critical Reviews in Oncology/Hematology publishes scholarly, critical reviews in all fields of oncology and hematology written by experts from around the world. Critical Reviews in Oncology/Hematology is the Official Journal of the European School of Oncology (ESO) and the International Society of Liquid Biopsy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信